Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Reexamination Certificate
2006-02-14
2009-10-20
Coleman, Brenda L (Department: 1624)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
C514S335000, C514S351000, C514S340000, C514S378000, C514S448000, C514S617000, C544S405000, C546S261000, C546S268400, C546S272100, C546S277400, C546S300000, C548S248000, C549S072000, C564S184000
Reexamination Certificate
active
07605164
ABSTRACT:
Certain substituted benzamide derivatives selectively modulate the cardiac sarcomere, for example by potentiating cardiac myosin, and are useful in the treatment of systolic heart failure including congestive heart failure.
REFERENCES:
patent: 3055905 (1962-09-01), Graf et al.
patent: 3448029 (1969-06-01), Weinberger
patent: 3577550 (1971-05-01), Moyle
patent: 3674850 (1972-07-01), Osborne
patent: 3862088 (1975-01-01), Wolf et al.
patent: 4783472 (1988-11-01), Fabre et al.
patent: 6001379 (1999-12-01), Griat
patent: 6001879 (1999-12-01), Seitz et al.
patent: 6143764 (2000-11-01), Kubo et al.
patent: 6207829 (2001-03-01), Dunn et al.
patent: 6355660 (2002-03-01), Ricks et al.
patent: 6410254 (2002-06-01), Finer et al.
patent: 6495337 (2002-12-01), Hartman et al.
patent: 6521622 (2003-02-01), Ricks et al.
patent: 6548549 (2003-04-01), Seitz et al.
patent: 6706740 (2004-03-01), Ricks et al.
patent: 6908923 (2005-06-01), Malik et al.
patent: 7053094 (2006-05-01), Malik et al.
patent: 31 39 457 (1983-04-01), None
patent: 2000-10010002 (2001-09-01), None
patent: 1 277 729 (2003-01-01), None
patent: 1 535 609 (2005-06-01), None
patent: 58-74665 (1983-05-01), None
patent: 2-115839 (1990-04-01), None
patent: 2-196769 (1990-08-01), None
patent: 3-292327 (1991-12-01), None
patent: 05-043556 (1993-02-01), None
patent: WO 93/17027 (1993-09-01), None
patent: WO 99/41239 (1999-08-01), None
patent: WO 01/05769 (2001-01-01), None
patent: WO 01/14339 (2001-03-01), None
patent: WO 01/64773 (2001-09-01), None
patent: WO 01/83427 (2001-11-01), None
patent: WO 03/037900 (2003-05-01), None
patent: WO 03/059258 (2003-07-01), None
patent: WO 03/103654 (2003-12-01), None
patent: WO 03/103655 (2003-12-01), None
patent: WO 03/103657 (2003-12-01), None
patent: WO 2004/001058 (2003-12-01), None
Chemcats Copyright 2004 ACS on STN, Registry No. 332035-74-2 “Benzamide, 4-[methyl(phenylsulfonyl)amino]-N-3-pyridinyl-.”.
Chemcats Copyright 2004 ACS on STN, 2004:1448030 Chemcats, ChemBridge Screening Library, May 19, 2004, Order No. 5734271, “4-[methyl(phenylsulfonyl)amino]-N-3-pyridinylbenzamide,” 332035-74-2.
Chemcats Copyright 2004 ACS on STN, 2003:2676485 Chemcats, TimTec Overseas Stock, May 19, 2003, Order No. OVS1270658, “Benzamide, 4-[methyl(phenylsulfonyl)amino]-N-3-pyridinyl-,” 332035-74-2.
Chemcats Copyright 2004 ACS on STN, 2003:2118551 Chemcats, AsInEx Express Gold Collection, Apr. 23, 2003, Order No. BAS 1979659, “Benzamide, 4-[methyl(phenylsulfonyl)amino]-N-3-pyridinyl-,” 332035-74-2.
Chemcats Copyright 2004 ACS on STN, 2003: 621761 Chemcats, Ambinter Screening Library, Jan. 1, 2004, Order No. 139969372, “Benzamide, 4-[methyl(phenylsulfonyl)amino]-N-3-pyridinyl-,” 332035-74-2.
Chemcats Copyright 2004 ACS on STN, 2002: 2006761 Chemcats, Interchim Intermediates, Jul. 9, 2002, Order No. BAS 1979659, “Benzamide, 4-[methyl(phenylsulfonyl)amino]-N-3-pyridinyl-,” 332035-74-2.
Kubo et al., 2003, “Synthesis and structure-activity relationship for new series of 4-Phenoxyquinoline derivatives as specific inhibitors of platelet-derived growth factor receptor tyrosine kinase,” Bioorganic & Medicinal Chemistry, 11(23): 5117-5133.
Künzle et al. 1969, “70. Dibenz[b,f]-1, 4-oxazepin-11 (10H)-one und Dibenz[b,e]-1, 4-oxazepin-11(5H)-one,” Helvetica Chimica Acta, 52: 622-628. (translation of abstract on p. 622).
“207 Registry Compounds Not Indexed in Chemical Abstracts (Free Scan Str Format)” Copyright 2004 ACS on STN.
Zlotin et al. (2000) “Synthetic Utilization of Polynitroaromatic Compounds. 1. S-Derivatization of 1-Substituted 2,4,6-Trinitrobenzenes with Thiols,” J. Org. Chem. 65(25), 8430-8438.
Shkinyova et al. (2000) “Regioselectivity of nucleophilic substitution of the nitro group in 2,4,6-trinitrobenzamide ,” Tetrahedron Letters 41(25) 4973-4975.
Shevelev et al. (1995) “Reaction of 1,3,5-Trinitrobenzene with Phenols: Synthesis of 3,5-Dinitrophenyl Aryl Ethers,” Mendeleev Commun. 5(4) 157-158.
Hawley's Condensed Chemical Dictionary, 12thed., Richard J. Lewis, Sr., © 1993 by Van Nostrand Reinhold, p. 594.
Concise Chemical Dictionary, edited by Drs. Hans-Dieter Jakubke and Hans Jeschkeit, © 1993 by Walter de Gruyter & Co., p. 490.
McGraw-Hill Dictionary of Chemical Terms, 3rded. edited by Sybil P. Parker, © 1984 McGraw-Hill, Inc., p. 200.
European Patent Office Communication and Supplementary Partial European Search Report mailed Oct. 19, 2005, for EP Patent Application No. 02806491.3.
International Search Report Jun. 3, 2003, for PCT Application No. PCT/US02/40996, filed Dec. 20, 2002.
International Preliminary Examination Report completed Mar. 1, 2004, for PCT Application No. PCT/US02/40996, filed Dec. 20, 2002.
Supplementary Partial European Search Report completed Oct. 12, 2005, for European Application No. EP02806491.
Office Action mailed Jul. 2, 2004, for U.S. Appl. No. 10/327,219, filed Dec. 20, 2002.
Notice of Allowance mailed Oct. 20, 2004, for U.S. Appl. No. 10/327,219, filed Dec. 20, 2002.
Notice of Allowance mailed Nov. 15, 2005, for U.S. Appl. No. 11/040,478, filed Jan. 20, 2005.
Elias Kathleen A.
Feng Bainian
Kraynack Erica Anne
Lu Pu-Ping
Malik Fady
Coleman Brenda L
Cytokinetics Inc.
Finnegan Henderson Farabow Garrett & Dunner LLP
Moore Susanna
LandOfFree
Compositions and methods for treating heart failure does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Compositions and methods for treating heart failure, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Compositions and methods for treating heart failure will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4119747